Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 68fludarabine phosphate 59Peripheral Blood Stem Cell Transplantation 51Cyclophosphamide 48Busulfan 46Tacrolimus 36Mycophenolic Acid 35Etoposide 33Cyclosporine 32Methotrexate 29Whole-Body Irradiation 28Antilymphocyte Serum 28Filgrastim 27Flow Cytometry 22Mitoxantrone 19Radiotherapy 18Daunorubicin 18Melphalan 16Idarubicin 16sargramostim 13Gene Expression Profiling 12Clofarabine 12Polymerase Chain Reaction 11Methylprednisolone 11Decitabine 10Cord Blood Stem Cell Transplantation 10merphos 9Transplantation 9Immunologic Techniques 9Granulocyte Colony-Stimulating Factor 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Congenital Abnormalities × Proto-Oncogene Proteins c-kit × Clear all
NCT00509093 2020-03-17

Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy

Case Comprehensive Cancer Center

Phase 2 Completed
32 enrolled 14 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡